Religare Enterprises has reported a consolidated net loss of ₹46.98 crore for the first quarter of FY27, which ended on June 30, 2026. The result marks a clear improvement from the consolidated loss of ₹95.65 crore in the fourth quarter of FY26.
The lower loss is important for the company because Religare has spent the past few quarters on business repair, better control and a stronger base for future growth. The latest result shows that the group has reduced the size of its loss, although it has not yet moved into a consolidated profit.
The company released its unaudited standalone and consolidated results after a board meeting on August 12, 2026. The results had a limited review by its statutory auditors.
Loss falls by almost half
The move from a loss of ₹95.65 crore in Q4 FY26 to ₹46.98 crore in Q1 FY27 means the quarterly loss fell by almost half. This is one of the main points investors may note from the result.
A lower loss does not mean that the company has fully solved its financial issues. It does, however, show that the pressure on the group has reduced when compared with the previous quarter.
Religare is a holding company with several businesses under its group. These include Care Health Insurance, Religare Broking, Religare Finvest and Religare Housing Development Finance Corporation. Each business has a different role, so the overall result depends on the performance of several parts of the group.
Standalone loss also becomes smaller
The company’s standalone performance also showed an improvement. Religare Enterprises posted a standalone net loss of ₹9.62 crore in Q1 FY27, compared with a loss of ₹12.37 crore in Q4 FY26.
Standalone total income rose to ₹4.38 crore from ₹3.35 crore in the previous quarter. This means the parent company itself had a better quarter, although its income base remained small.
The gap between the standalone loss and the consolidated loss is important. The consolidated number covers the wider group and therefore reflects the results of its operating subsidiaries. The performance of businesses such as health insurance and broking has a much larger effect on the final consolidated figure.
Care Health Insurance remains a key business
Care Health Insurance remains one of the most important parts of the Religare group. The company reported a 37% year-on-year rise in gross written premium, or GWP, to ₹3,247 crore.
GWP is the total premium value that an insurance company receives before adjustments for items such as reinsurance. A rise in this figure shows that the insurance business has a larger premium base than it had a year earlier.
For Religare, this is a useful sign because Care Health Insurance is one of the group’s main operating businesses. A stronger premium base can help the company build scale, although premium growth alone does not guarantee higher profit. Claims, expenses and other costs also affect the final result.
The performance of Care Health Insurance will therefore remain important for Religare in the next few quarters. The company needs growth in premiums along with better control of costs and claims if it wants the business to make a stronger contribution to group earnings.
Religare Broking also shows better results
Religare Broking was another positive part of the quarter. Its profit after tax rose 65%, according to the Q1 FY27 update.
This is important because the broking business can benefit from higher customer activity and greater use of market services. Religare’s website says its broking arm has more than 1 million customers and provides services across equity, currency, commodity and depository segments.
A 65% rise in profit after tax suggests that the business had a much better profit profile during the quarter. It also adds support to the wider group at a time when the parent company still has a consolidated loss.
FY26 gave the group a larger base
Religare entered FY27 after a year of major financial and business changes. For FY26, the company reported consolidated revenue of ₹8,493.84 crore. In Q4 FY26, consolidated revenue stood at ₹2,049.82 crore.
The FY26 result also showed that the company had a much larger revenue base than in FY25. The group had reported consolidated revenue of ₹7,405.47 crore in FY25.
This gives some context to the Q1 FY27 result. Religare is not a small single-business company. Its results reflect several financial services businesses, and the group needs steady performance across these units to convert its larger revenue base into consistent profit.
Capital support remains important
Religare has also taken steps to support its businesses with fresh capital. Earlier in FY26, the company raised ₹1,500 crore at the holding company level. The planned use of this money included ₹600 crore for Care Health Insurance, ₹250 crore for the housing finance business and ₹200 crore for the broking business, with around ₹375 crore kept for general corporate purposes.
The capital gives the group more room to support growth across its businesses. It can also help the company strengthen its balance sheet and provide funds for expansion where required.
Religare has also completed a rights issue subscription in Care Health Insurance and converted warrants into equity. These steps form part of the company’s wider effort to strengthen its business structure and capital position.
RBI decision adds another factor
The Q1 FY27 result comes at a time when Religare also faces an important regulatory development. The Reserve Bank of India declined the company’s demerger application on August 6, 2026.
This decision is separate from the quarterly financial result, but it matters for investors because the company’s future structure and capital plans can affect how its businesses operate under the group.
The company has also made a change at the top level. Its board approved the re-designation of Arjun Lamba as Managing Director with effect from August 12, 2026, subject to shareholder approval. He had earlier served as an Executive Director and Whole-time Director.
What the Q1 result means
The main message from the Q1 FY27 result is simple: Religare has reduced its loss, but the turnaround is not complete.
A consolidated loss of ₹46.98 crore is still a loss. At the same time, the fall from ₹95.65 crore in Q4 FY26 is a positive change. The smaller standalone loss, stronger Care Health Insurance premium growth and higher profit at Religare Broking add further support to the quarter.
The next step will be to see whether this improvement can continue. One better quarter is not enough to prove a full turnaround. Investors will want to see steady results from the operating businesses, better cost control and a clear path toward regular consolidated profit.
Focus now shifts to the next quarters
Religare now enters the rest of FY27 with several important tasks. Care Health Insurance needs to maintain its strong premium growth while keeping claims and costs under control. Religare Broking needs to protect its higher profit level. The housing finance and other financial services businesses also need to add more value to the group.
The company also needs to manage its capital well after the ₹1,500-crore fund raise and deal with the impact of the RBI’s decision on the proposed demerger.
For now, the Q1 FY27 numbers offer a better picture than the previous quarter. The consolidated loss has fallen to ₹46.98 crore from ₹95.65 crore, while the standalone loss has declined to ₹9.62 crore from ₹12.37 crore.
The result is therefore a step in the right direction, but not the final stage of the turnaround. The real test for Religare will be whether it can turn this lower loss into a stable profit in the quarters ahead.
ALSO READ: Yatra Online Q1 FY27: Profit Falls 98% as MICE Hits
